Period of time： 2013年3期
Publisher： Future Science
Founded in： 2012
Total resources： 5
ISSN： 2046-8954
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Pharmaceutical Patent Analyst,volume 2,issue 3
Menu
Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters
By von Falck Andreas,Gundt Miriam in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.
Access to resources
Recommend
Different rules, different results: patent litigation after In re Baxter
By Vogel Bryan J,Roberg-Perez Sharon E in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.By D'Oca Gino,Sklan Alexandra,Komatani Takeshi S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.Legitimate patent extension or patent system abuse?
By Atkinson Jonathan DM,Moodie Rachel S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.Challenges to obtaining good pharmaceutical patents in Japan: 2009 and beyond
By Komatani Takeshi S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.Current trends in the development of wound dressings, biomaterials and devices
By Martin Claire,Low Wan Li,Amin Mohd Cairul Iqbal Mohd,Radecka Iza,Raj Prem,Kenward Ken in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.New immunological approaches in treating and diagnosing CNS diseases
By Guo Kathy,Janigro Damir in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.Newer glucocorticosteroids and corticosteroid resistance reversal in asthma
Pharmaceutical Patent Analyst,volume 2,issue 3 , Vol. 2, Iss. 3, 2013-05 , pp.
Previous
Next